Following China's loosening of pandemic control measures earlier this month, the number of cases across the country has soared, while demand for drugs and medical supplies such as antipyretics, antigen tests and oximeters has skyrocketed.
During this year's INNO DAY 2022, Chinese smartphone manufacturer OPPO unveiled the first product under its OHealth brand, the OHealth H1 family health monitor, alongside its second self-developed chip, the MariSilicon Y Bluetooth audio SoC, and OPPO Air Glass 2.
Beijing-based tech firm Xiaomi announced it will rename its sports app to "Zepp Life."
Tencent's TiMi Studio Group announced on Monday that it will launch Tianmei Health, a sub-brand focusing on sports and wellness.
On Thursday, Boohee, a health management platform, announced its completion of a D2 round of financing, totaling 100 million yuan ($15.6 million), with investment exclusively from SCGC.
Chinese health food brand Sharkfit completed A round of financing worth 15 million yuan backed by Plum Ventures, 36Kr reported.
Several interesting news surfaced last week, with China’s VC industry getting back on its feet.
Chinese health authorities are investigating an alleged faulty herbal medicine from Quanjian group that might be related to the death of a 4-year-old child back in 2015. According to South China Morning Post, the investigation was conducted under high priorities and is considered of high importance.